We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
+21.96%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$1.63M
Cap. Flow
-$10.4M
Cap. Flow %
-10.37%
Top 10 Hldgs %
78.19%
Holding
48
New
18
Increased
3
Reduced
4
Closed
16

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$26.5M
2
TECD
Tech Data Corp
TECD
+$6.63M
3
MDCO
Medicines Co
MDCO
+$3.87M
4
WMGI
Wright Medical Group Inc
WMGI
+$3.85M
5
PPLI
People Inc
PPLI
+$2.92M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$22M
2
AABA
Altaba Inc
AABA
+$15.1M
3
MLNX
Mellanox Technologies, Ltd.
MLNX
+$4.39M
4
CNC icon
Centene
CNC
+$3.65M
5
AMCR icon
Amcor
AMCR
+$3.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 31.25%
2 Healthcare 18.37%
3 Technology 11.17%
4 Communication Services 5.93%
5 Materials 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCK icon
26
Crown Holdings
CCK
$12.8B
$677K 0.67%
+9,339
New +$666K
AXE
27
DELISTED
Anixter International Inc
AXE
$594K 0.59%
+6,451
New +$523K
PKX icon
28
POSCO
PKX
$16.1B
$554K 0.55%
10,951
– –
PTR
29
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$426K 0.42%
8,473
– –
VNET
30
VNET Group
VNET
$2.04B
$374K 0.37%
51,525
-23,518
-31% -$179K
PACB icon
31
Pacific Biosciences
PACB
$435M
$357K 0.36%
+69,420
New +$353K
CO
32
DELISTED
Global Cord Blood Corporation
CO
$299K 0.3%
59,862
+24,850
+71% +$119K
AMCR icon
33
Amcor
AMCR
$20.8B
– –
-71,860
Closed -$3.5M
CNC icon
34
Centene
CNC
$30.7B
– –
-84,428
Closed -$3.65M
HCM icon
35
HUTCHMED
HCM
$1.93B
– –
-85,815
Closed -$1.53M
HHH icon
36
CALL
Howard Hughes
HHH
$3.81B
– –
-6,084
Closed -$752K
MPC icon
37
Marathon Petroleum
MPC
$92.4B
– –
-22,528
Closed -$1.41M
TAK icon
38
Takeda Pharmaceutical
TAK
$54.6B
– –
-27,163
Closed -$467K
TSM icon
39
TSMC
TSM
$2.1T
– –
-54,906
Closed -$2.55M
ZEPP
40
Zepp Health
ZEPP
$66.4M
– –
-50,587
Closed -$2.02M
CIR
41
DELISTED
CIRCOR International, Inc
CIR
– –
-12,489
Closed -$469K
SINA
42
DELISTED
Sina Corp
SINA
– –
-42,027
Closed -$1.65M
WBC
43
DELISTED
WABCO HOLDINGS INC.
WBC
– –
-13,908
Closed -$1.86M
MLNX
44
DELISTED
Mellanox Technologies, Ltd.
MLNX
– –
-40,083
Closed -$4.39M
ONCE
45
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-22,139
Closed -$2.15M
CBLK
46
DELISTED
Carbon Black, Inc. Common Stock
CBLK
– –
-67,075
Closed -$1.74M
AABA
47
DELISTED
Altaba Inc
AABA
– –
-774,856
Closed -$15.1M
CELG
48
DELISTED
Celgene Corp
CELG
– –
-221,964
Closed -$22M
1
2

Similar funds

THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return
WG
Wellington Group Indianapolis, Indiana $325M AUM
FAL
Focused Alpha LLC Denver, Colorado $324M AUM
AIA
AIMZ Investment Advisors Los Altos, California $324M AUM 18.77% 1-Year Est. Return
DMC
DSC Meridian Capital New York $325M AUM 45.4% 1-Year Est. Return
KL
Knox Lane San Francisco, California $325M AUM
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
MFA
Morling Financial Advisors Fremont, California $325M AUM 21.97% 1-Year Est. Return

Athos Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Athos Capital held 48 positions worth $100M, down 1.6% from $102M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Athos Capital withdrew a net $10.4M in Q4 2019, closing 16 positions and reducing 4 holdings. Its most notable exit was Celgene Corp, an estimated $22M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, up from 7.5% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Athos Capital opened a new position in Alibaba worth $29.9M.

  • Athos Capital's largest Q4 2019 buy was Alibaba: 140,965 shares worth $29.9M.
  • Athos Capital added most to Bitauto Holdings Limited in Q4 2019, an estimated $1.97M increase.
  • Athos Capital's biggest Q4 2019 reduction was BHP, cutting an estimated $2.71M.
  • Athos Capital fully exited Celgene Corp in Q4 2019, selling an estimated $22M.
  • Athos Capital's ten largest holdings make up 78% of its $100M portfolio in Q4 2019.
  • Athos Capital opened 18 new positions and closed 16 in Q4 2019.
  • Athos Capital's portfolio value fell 1.6% quarter-over-quarter to $100M.

Based on Athos Capital's 13F filing for Q4 2019, filed 11 Feb 2020.